Trials / Completed
CompletedNCT00163176
Value of FLT-PET Before and During Radiotherapy in Head and Neck Tumors
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (actual)
- Sponsor
- Radboud University Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Tumor cell proliferation and repopulation contribute to resistance to radiotherapy in head and neck cancer. Up to now, this characteristic is mostly assessed using biopsies acquired during inspection under general anaesthesia before treatment. 18F-FLT-PET (positron emission tomography) is a non-invasive imaging method showing areas of active proliferation. The aim of this study is to assess the value of the functional information gained by 18F-FLT-PET for radiotherapy planning and early tumor response assessment. Prior to radiotherapy, a planning CT-scan and a 18F-FLT-PET scan are acquired. After approximately two weeks of radiotherapy a further PET scan is obtained.
Conditions
Timeline
- Start date
- 2005-07-01
- Primary completion
- 2008-12-01
- Completion
- 2010-12-01
- First posted
- 2005-09-13
- Last updated
- 2011-12-16
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT00163176. Inclusion in this directory is not an endorsement.